MTM(SH:688029) Xin Lang Cai Jing·2025-12-30 05:26Group 1 - The core point of the news is that Nanwei Medical has experienced a decline in stock price, dropping 1% to 81.83 CNY per share, with a total market capitalization of 15.372 billion CNY and a cumulative decline of 1.89% over three consecutive days [1] - Nanwei Medical, established on May 10, 2000, and listed on July 22, 2019, specializes in the research, manufacturing, and sales of minimally invasive medical devices [1] - The revenue composition of Nanwei Medical is as follows: endoscopic consumables account for 77.80%, other categories 13.17%, tumor intervention 7.28%, visualization 1.00%, and other supplementary items 0.74% [1] Group 2 - From the perspective of fund holdings, Huashang Fund has one fund heavily invested in Nanwei Medical, specifically the Huashang Innovation Medical Mixed A fund, which reduced its holdings by 8,352 shares in the third quarter [2] - The current holding of the Huashang Innovation Medical Mixed A fund is 20,000 shares, representing 3.85% of the fund's net value, ranking as the ninth largest holding [2] - The fund has experienced a year-to-date return of 25.18% and a one-year return of 23.02%, with a total fund size of 31.7429 million CNY [2]